Mustang Bio (MBIO) Current Leases (2019 - 2024)
Mustang Bio (MBIO) posted quarterly Current Leases of $456000.0 for Q4 2024, down 12.31% year-over-year from $520000.0 in Q1 2024, and up 3.17% quarter-over-quarter from $442000.0 in Q3 2024.
Mustang Bio (MBIO) Current Leases (2019 - 2024) Analysis & Trends
Mustang Bio (MBIO) has reported Current Leases for 6 consecutive years, with $456000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Current Leases fell 12.31% year-over-year to $456000.0; the TTM figure through Dec 2024 stood at $456000.0 (down 12.31% YoY), while the FY2024 annual figure was $456000.0, down 12.31% from the prior year.
- Current Leases advanced to $456000.0 in Q4 2024 per MBIO's latest filing, from $442000.0 in the prior quarter.
- Across five years, Current Leases topped out at $629000.0 in Q1 2023 and bottomed at $257000.0 in Q1 2020.
- Historically, Current Leases has averaged $410950.0 across 5 years, with a median of $388500.0 in 2022.
- Annual changes were most pronounced in 2020 — Current Leases jumped 159.6% — and 2023, when it slipped 23.87%.
- Mustang Bio's Current Leases stood at $278000.0 in 2020, then climbed by 25.18% to $348000.0 in 2021, then jumped by 75.86% to $612000.0 in 2022, then dropped by 15.03% to $520000.0 in 2023, then dropped by 12.31% to $456000.0 in 2024.
- Business Quant data shows MBIO's Current Leases at $456000.0 in Q4 2024, $442000.0 in Q3 2024, and $429000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Mustang Bio | 3.82 Mn | 3.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 456,000.00 |
| Sep 30, 2024 | 442,000.00 |
| Jun 30, 2024 | 429,000.00 |
| Mar 31, 2024 | 570,000.00 |
| Dec 31, 2023 | 520,000.00 |
| Sep 30, 2023 | 453,000.00 |
| Jun 30, 2023 | 409,000.00 |
| Mar 31, 2023 | 629,000.00 |
| Dec 31, 2022 | 612,000.00 |
| Sep 30, 2022 | 595,000.00 |
| Jun 30, 2022 | 368,000.00 |
| Mar 31, 2022 | 358,000.00 |
| Dec 31, 2021 | 348,000.00 |
| Sep 30, 2021 | 329,000.00 |
| Jun 30, 2021 | 346,000.00 |
| Mar 31, 2021 | 284,000.00 |
| Dec 31, 2020 | 278,000.00 |
| Sep 30, 2020 | 271,000.00 |
| Jun 30, 2020 | 265,000.00 |
| Mar 31, 2020 | 257,000.00 |